A Study of Recent Advances in Systems Biology of Pseudomonas in Biotechnology

Biotechnology

Engineering and changing synthetic microbial chassis is one of the most effective ways to not only understand the underlying principles of life, but also to improve applications in health, medicine, agriculture, veterinary medicine, and food. The top-down strategy (genome reduction) and the bottom-up approach (genome expansion) are the two basic strategies for developing a microbial chassis (genome synthesis). Several nations have financed research studies on this subject. The 'Minimum genome factory' (MGF) initiative began in Japan in 2001 with the purpose of creating microorganisms with reduced genomes for industrial use. The 'cell factory' project, which ran from 1998 to 2002 as part of the EU's Fifth Framework Program, aimed to get a complete understanding of microorganisms utilized in the application sector. The elucidation of proteins produced by Bacillus subtilis, known as the'secretome,' was one of the project's most notable outcomes. In the United States, the GTL (Genomes to Life) initiative began in 2002. Researchers in this programme tried to develop artificial cells both in silico and in vitro, such as John Craig Venter's group's successful design and manufacture of a minimum bacterial genome. This study gives an update on recent breakthroughs in synthetic microbial chassis engineering, modification, and application, with a focus on the importance of learning about chassis as a tool to better understand life and enhance applications.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.